Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO2 pseudogene 12 (MTCO2P12) is classified as an unprocessed pseudogene found on chromosome 1p36.33. Unlike the functional mitochondrial MT-CO2 gene, which encodes a protein vital for the electron transport chain (cytochrome c oxidase subunit II), the pseudogene MTCO2P12 does not produce a functional protein and lacks a biological role in mitochondrial respiration or known disease mechanisms. It is not considered a drug target, nor is it relevant for biomarker or safety considerations. MTCO2P12 is likely annotated due to sequence similarity to MT-CO2 but serves no established function in human health or disease[2][5][8]. MTCO2P12 is a pseudogene and not a functional therapeutic target, enzyme, receptor, or transporter. It should not be considered for drug targeting or disease association studies other than pseudogene research or evolutionary studies[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase II pseudogene 12 (MTCO2P12).